Ashley Kalinauskas is the founder and CEO of Torigen Pharmaceuticals Inc., a veterinary pharmaceutical company currently testing a cancer vaccine for pets. HBJ PHOTO SEAN TEAHAN Farmington-based ...
FARMINGTON, Conn. and PHILADELPHIA, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Torigen Pharmaceuticals, recognized for pioneering cancer immunotherapy in veterinary medicine, is using software from Proscia ®, ...
A Farmington-based animal pharmaceutical company has partnered with Vidium Animal Health to offer veterinarians cancer diagnosis and treatment services. The partnership will enable Torigen ...
There is new hope for animals diagnosed with cancer here in Connecticut. An experimental immunotherapy cancer treatment for pets being made in Farmington is making progress and could have the ...
FARMINGTON, Conn., Nov. 5, 2019 /PRNewswire-PRWeb/ -- Torigen Pharmaceuticals Inc., a commercial-stage companion animal immuno-oncology company, today announced the addition of two deeply experienced ...
FARMINGTON, Conn., Feb. 4, 2019 /PRNewswire-PRWeb/ -- Torigen Pharmaceuticals, a company developing personalized cancer immunotherapies for the veterinary market, announced today the completion of a ...
Torigen Pharmaceuticals, Inc (Farmington, CT), an animal health biologics company, today announced it has entered into a Preferred Partner Agreement with Veterinary Management Groups (VMG) to provide ...
FARMINGTON, Conn., May 7, 2019 /PRNewswire-PRWeb/ -- Torigen Pharmaceuticals Inc., a startup in companion animal immuno-oncology, announces its founder and chief executive officer, Ashley Kalinauskas, ...
Agreement provides member clinics and their patients with access to innovative companion animal cancer therapy Torigen offers an experimental autologous cancer immunotherapy created from a surgically ...